LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes
- 1 June 2015
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 39 (6) , 649-656
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (R41CA173900)
- St. Baldrick's Foundation (244708)
- New Jersey Commission on Cancer Research (10-1072-CCR-EO)
This publication has 39 references indexed in Scilit:
- Leukotoxin (Leukothera®) Targets Active Leukocyte Function Antigen-1 (LFA-1) Protein and Triggers a Lysosomal Mediated Cell Death PathwayJournal of Biological Chemistry, 2012
- HIV Envelope gp120 Activates LFA-1 on CD4 T-Lymphocytes and Increases Cell Susceptibility to LFA-1-Targeting Leukotoxin (LtxA)PLOS ONE, 2011
- MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failureExperimental Hematology, 2011
- Aggregatibacter actinomycetemcomitans leukotoxin is post‐translationally modified by addition of either saturated or hydroxylated fatty acyl chainsMolecular Oral Microbiology, 2011
- Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxinCell Death & Disease, 2011
- Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cellsLeukemia Research, 2010
- Aggregatibacter actinomycetemcomitans LeukotoxinJournal of Dental Research, 2010
- Human CD18 Is the Functional Receptor forAggregatibacter actinomycetemcomitansLeukotoxinInfection and Immunity, 2007
- Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicityCellular Microbiology, 2006
- Comparative studies on the biology of Actinobacillus actinomycetemcomitans leukotoxin in primatesOral Microbiology and Immunology, 1987